{"slideshow_credits": null, "snippet": "Experts are considering ways to speed the approval of new medicines to combat antibiotic-resistant infections, but high costs and safety concerns have complicated their efforts.", "abstract": "Government officials, drug companies and medical experts are pushing to speed up approval of new antibiotics due to threat of outbreaks of antibiotic-resistant superbugs; critics of speeding up approval process warn of safety concerns.", "section_name": "Health", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "Barry", "role": "reported", "lastname": "MEIER", "rank": 1, "organization": ""}], "original": "By BARRY MEIER", "contributor": ""}, "web_url": "http://www.nytimes.com/2013/06/03/health/experts-debate-plan-to-speed-antibiotic-development.html", "lead_paragraph": "Experts are considering ways to speed the approval of new medicines to combat antibiotic-resistant infections, but high costs and safety concerns have complicated their efforts.", "headline": {"seo": "Experts Debate Plan to Speed Antibiotic Development", "main": "Pressure Grows to Create Drugs for \u2018Superbugs\u2019", "print_headline": "Pressure Grows To Create Drugs For \u2018Superbugs\u2019"}, "_id": "51abf63840e9ec65d203ae01", "word_count": "1193", "multimedia": [{"height": 126, "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 395, "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-articleLarge.jpg", "legacy": {"xlarge": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "395"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/06/03/us/ANTIBIOTICS/ANTIBIOTICS-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-06-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Antibiotics", "name": "subject", "is_major": "Y", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "Law and Legislation", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Health and Human Services Department", "name": "organizations", "is_major": "N", "rank": "4"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "N", "rank": "5"}, {"value": "Food and Drug Administration", "name": "organizations", "is_major": "N", "rank": "6"}, {"value": "Medicine and Health", "name": "subject", "is_major": "Y", "rank": "7"}], "blog": [], "subsection_name": null, "type_of_material": "News"}